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Abstract While non-reactivability of cholinesterases from their 
phosphyl conjugates (aging) is attributed to an unimolecular 
process involving loss of alkyl group from the phosphyl moiety, 
no conclusive evidence is available that this is the only reaction 
path and involvement of other post-inhibitory processes cannot be 
ruled out. To address this issue, molecular masses of the 
bacterially expressed recombinant human acetylcholinesterase 
and of its conjugates with a homologous series of alkyl methyl-
phosphonofluoridates, were measured by electrospray-ionization 
mass spectrometry (ESI-MS). The measured mass of the free 
enzyme was 64 700 Da (calculated 64 695 Da) and those of the 
methylphosphono-HuAChE adducts, bearing isopropyl, isobutyl, 
1,2-dimethylpropyl and 1,2,2-trimethylpropyl substituents, were 
64820, 64840, 64852 and 64860 Da, respectively. These values 
reflect both the addition of the phosphonyl moiety and the 
gradual mass increase due to branching of the alkoxy substituent. 
The composition of these adducts change with time to yield a 
common product with molecular mass of 64780 Da which is 
consistent with dealkylation of the phosphonyl moieties. 
Furthermore, in the case of 1,2-dimethylpropyl methylphos-
phono-HuAChE, the change in the molecular mass and the 
kinetics of non-reactivability appear to occur in parallel 
indicating that dealkylation is indeed the predominant molecular 
transformation leading to 'aging' of phosphonyl-AChE adducts. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The catalytic power of acetylcholinesterase (AChE, EC 
3.1.1.7), which is among the most efficient enzymes with turn-
over number of > 104 s_1 (for recent reviews, see [1,2]), is 
believed to be a consequence of the unique architecture of 
its active center [2-15]. This architecture can also account 
for the marked stereospecificity toward certain alkyl methyl-
phosphonofiuoridates and methylphosphonothioates [16-18]. 
The phosphonylation is thought to proceed through an in-
line displacement reaction at the phosphorus to form a stoich-
*Corresponding author. Fax: (972) 8-9401404. 
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iometric (1 : 1) and stable conjugate through inversion of con-
figuration around the phosphorus [19-21]. The post-inhibitory 
behavior of phosphonyl-AChE adducts has been examined 
mainly through the facility of reactivation of the enzyme by 
reaction with nucleophilic agents, such as quaternary oximes 
or fluoride ions [22,23]. Non-reactivability of the adducts is 
usually associated with a unimolecular process which involves 
a loss of an alkyl group from the phosphonyl alkoxy substitu-
ent and is termed 'aging' [24-28]. 
In certain cases, resistance to reactivation of phosphonyl-
AChE conjugates, like that of (P+)-cycloheptyl methylphos-
phono-AChE [21], may not be due to the classical 'aging' 
mechanism. The non-reactivability in these cases can originate 
from the inability of the protein to regain the conformation-
ally active form following inhibition, even though displace-
ment of the phosphyl moiety from the active site serine has 
actually occurred [29]. In addition, non-reactivability may in 
principle also occur through a path for the decomposition of 
phosphonyl-AChE adducts which is different from the classi-
cal 'aging' [30,31]. One of the reasons for the difficulty to 
estimate the importance of those mechanisms to the reactiv-
ability of phosphonyl-AChE adducts, was that the variations 
in composition of these enzyme adducts could not be deter-
mined. 
Structures of several serine hydrolase phosphyl conjugates 
were determined by X-ray crystallography [32-35]. Such data 
are not available for cholinesterases and the nature of the 
corresponding phosphyl adducts can be inferred mainly 
from analogies to other hydrolases. To date, structures of 
aged cholinesterase conjugates could be suggested only on 
the basis of capture of low molecular mass decomposition 
products (corresponding alkyl alcohol or alkene) [25] and 
more recently by NMR studies [26]. Although these results 
are consistent with the commonly accepted structure of the 
aged phosphyl-AChE conjugate, an unequivocal evidence re-
garding its composition is not yet available. 
Here we report that the chemical composition of certain 
phosphonyl adducts of HuAChE can be directly measured 
by electrospray-ionization mass spectrometry (ESI-MS). In 
this method, the molecular mass of HuAChE and its phos-
phonyl adducts has been measured accurately allowing also to 
monitor the post-inhibitory processes on a molecular level. In 
the absence of X-ray structures for the different phosphyl-
cholinesterase conjugates, these mass spectrometric results 
represent a direct evidence for their chemical identity. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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Scheme 1. Generation and 'aging' of phosphonylated AChE. 
2. Materials and methods 
2.1. Enzymes reagents and inhibitors 
Wild-type (WT) recombinant HuAChE and its monomeric mutant 
C580A were expressed in 293 cells and purified as described before 
[5,8]. The monomeric C580S bacterially expressed enzyme (HuAChE-
bac) was expressed in E. coli [36] with an N-terminus sequence Met-
Glu-Gly-Arg-. Acetylthiocholine iodide (ATC) and 5 : 5'-dithiobis (2-
nitrobenzoic acid) (DTNB) were purchased from Sigma. l-(2-
hydroxyimino-methylpyridinium)-1 -(4-carboxyimino-pyridinium) di-
methylether dichloride (HI-6) was a gift from Dr. G. Amitai. Prepa-
ration of the racemic mixtures of 2-propyl, 2-butyl and 1,2-dimethyl-
propyl methylphosphonofluoridates, used in this study, followed an 
accepted synthetic procedure using methylphosphonodifluoride [37] 
and the appropriate alcohol. The purified stereoisomers (C+P+)-
and (C+P—)-l,2,2-trimethylpropyl methylphosphono-fluoridates were 
isolated as described before [38]. 
2.2. Kinetic studies 
HuAChE activity was assayed according to Ellman et al. [39] (in the 
presence of 0.1 mg/ml BSA, 0.3 mM DTNB, 50 mM sodium-phos-
phate buffer pH 8.0 and various concentrations of ATC), carried out 
at 27°C and monitored by a Thermomax microplate reader (Molec-
ular Devices). 
Measurements of phosphonylation rates, with the mammalian re-
combinant HuAChE, were carried out in at least four different con-
centrations of the alkyl methylphosphonofluoridates (1) and enzyme 
residual activity (E) at various times was monitored (see Scheme 1). 
The apparent bimolecular phosphonylation rate constants (k\) deter-
mined under pseudo-first order conditions were computed from the 
plot of slopes of \n(E) vs. time at different inhibitor concentrations. 
Rate constants under second order conditions were determined from 
plots of ln{EI[I0-(E0-E)]} vs. time [28]. 
The stabilities of the HuAChE phosphono conjugates were eval-
uated under conditions where the rate of phosphonylation is much 
higher than the rate of aging (k[[I0]»-k&, see Scheme 1) and with 
> 98% inhibition of the initial enzyme activity. The excess inhibitor 
was rapidly removed either by column filtration (Sephadex, G-15) or 
by 1000-fold dilution, prior to reactivation. The reactivatable (non-
aged methylphosphono conjugate) fraction was determined by reacti-
vation with 0.5 mM HI-6 under conditions where the rate of reacti-
vation is higher than the rate of aging (see Scheme 1) [28]. 
2.3. Mass spectrometric analysis 
Molecular mass measurements were carried out on a VG Platform 
mass spectrometer which consists essentially of an electrospray ion 
source operating at atmospheric pressure followed by a quadrupole 
mass analyzer. Samples of HuAChE-bac and of the phosphonyl-Hu-
AChE conjugates, prepared by mixing the enzyme (30^10 pmol/|il) 
with an excess of appropriate phosphonofluoridate, were introduced 
directly into the ion source in a 50 :50 acetonitrile-water solutions. 
The flow rate of the sample solution into the ion source was 20 [ill 
min. The mass spectrometer was scanned, in positive ion mode, from 
m/z 500 to 1900 in 10 s and several scans were summed to obtain the 
final spectrum. Mass-scale calibration employed the multiply charged 
ions from a separate introduction of myoglobin. 
The multiply charged electrospray ionization mass spectra were 
converted to the true molecular mass spectra using the VG MaxEnt 
algorithm of the MassLynx NT software. Molecular mass calculations 
of homogeneous samples were carried out over a mass range of 
50000-80000 Da (see Figs. 1 and 3) whereas a narrower mass range 
(64000-66000 Da) was used for the case of 1,2-dimethylpropyl meth-
ylphosphono-HuAChE (see Fig. 2). At least 5 mass determinations 
were carried out for each of the molecular species reported, yielding 
every time exactly the same values (within the experimental resolution 
of 1 Da). 
Similar experiments aimed to obtain molecular masses for either the 
WT HuAChE or the monomeric C580A mutant, expressed in mam-
malian cells, were unsuccessful. Scanning in positive or negative ion 
modes and at higher resolution (peak width at half height of £0.75 
Da) failed to produce spectra in which discrete multiply charged spe-
cies could be isolated. 
3. Results and discussion 
ESI-MS is a new mass spectrometric method that has been 
recently applied to the detection of covalent enzyme-substrate 
and enzyme-inhibitor complexes as well as for probing pro-
tein-ligand non-covalent interactions [40-42]. One of its 
unique features is that the protein sample is introduced di-
rectly from solution, in its biologically active form, for mass 
spectrometry analysis. The ESI is not expected to facilitate 
chemical changes of covalent conjugates during the ionization 
process and, therefore, is suitable to monitor the post-inhib-
itory behavior of phosphyl-AChE adducts. 
To examine the potential utility of ESI-MS to such study, 
we attempted to determine the molecular mass of the Hu-
AChE recombinant enzyme expressed in human embryonal 
293 cells [5], by direct introduction into the ion source. How-
ever, the resulting signal could not be resolved into discrete 
masses, indicating a mixture of molecular species which may 
originate from oligomerization and post-translational modifi-
cations of the protein [1]. To overcome this problem, we 
measured, in the same manner, the mass spectrum of the 
C580A mutant enzyme in which replacement of the C-termi-
nal cysteine prevents oligomerization and the protein is mono-
meric [5]. In this case, we still could not obtain a discrete 
molecular mass, probably due to the variable sugar composi-
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Fig. 1. Positive-ion ESI-MS mass spectra of HuAChE-bac and of its alkyl methylphosphono conjugates, after processing by VG MaxEnt soft-
ware. Spectra of the adducts were measured within 2-A min of mixing the enzyme with excess of the phosphonylating agent, as shown in each 
of the panels: (A) free C580S HuAChE-bac (mass calculated from sequence 64695 Da); (B) 2-propyl methylphosphono-HuAChE-bac (mass 
calculated 64 821 Da); (C) 2-butyl methylphosphono-HuAChE-bac (calculated 64 835 Da); (D) product of phosphonylation with (C+P+)-l,2,2-
trimethylpropyl methylphosphono-fluoridate (calculated 64863 Da), spectrum taken after 40 min since in this case adduct formation is very 
slow; (E) product of phosphonylation with (C+P—)- 1,2,2-trimethylpropyl methylphosphonofluoridate (calculated 64 778 Da for the aged ad-
duct, see text and Fig. 3). The minor peaks in the spectra may reflect the inherent 'noise' of the method. It should be pointed out that the 
peak height is a reflection of the precision as well as of the abundance of the corresponding molecular species in the sample. 
tion of the enzyme glycosyl substituents and variability of the 
glycosylation pattern [43]. Such variability appears to be char-
acteristic to HuAChEs where all the three potential N-glyco-
sylation sites are utilized but not all the secreted molecules are 
fully glycosylated [44,45]. Consequently, we decided to exam-
ine the monomeric form of HuAChE (C580S) expressed in E. 
coli (HuAChE-bac) which is not glycosylated. In the past, it 
was demonstrated that oligomerization or the extent of glyco-
sylation of HuAChE has practically no effect on either cata-
lytic activity or on reactivity towards active center ligands 
[45]. For the HuAChE-bac, the molecular mass could indeed 
be determined by ESI-MS (see Fig. 1A). The measured mo-
lecular mass (64700 Da) is consistent with that calculated 
(64 695 Da) for a bacterial HuAChE (C580S) sequence con-
taining methionine at the N-terminus. 
Following the determination of HuAChE-bac molecular 
mass, we examined the feasibility of measuring the composi-
tion of its phosphonyl adducts. Since for some methylfiuoro-
phosphonates (like soman or DMPF, see Scheme 1) the initial 
phosphonyl-HuAChE conjugate could be expected to undergo 
fairly rapid post-inhibitory transformations [46,47], the mass 
spectrometric experiments had to be carried out immediately 
after the phosphonylation. In addition, the reaction had to be 
carried out under conditions where the phosphonylation reac-
tions were rapid but the development of non-reactivability 
was relatively slow. To determine accurately these boundary 
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Fig. 2. Positive-ion ESI-MS mass spectra of the reaction mixture DMPF+HuAChE-bac sampled at different times after the reaction onset. 
Mean molecular mass of the mixture components was obtained for each spectrum after processing by the VG MaxEnt software. Although the 
value after 10 min corresponds closely to that calculated for 1,2-dimethylpropyl methylphosphono-HuAChE-bac (64849 Da), the asymmetric 
shape of the peak indicates an additional component with a lower molecular mass. Both the shapes and the mean values of the peaks, obtained 
after 20 and 40 min, suggest a gradual transition from a species with molecular mass of 64 852 Da to one with molecular mass of 64 780 Da 
(see also Fig. 3B). 
conditions, the rates of HuAChE phosphonylation with the 
homologous series of alkyl methylphosphonofiuoridates (so-
man, DMPF, IBMPF, sarin) and the stabilities of the corre-
sponding phosphonyl-HuAChE conjugates were measured 
(see Table 1). The actual measurements were carried out by 
reacting the enzyme with excess diastereomeric mixtures of 
DMPF, IBMPF and sarin and subjecting the reaction solu-
tions to mass spectrometric analysis 2-4 min after the reaction 
onset. On the other hand, in the case of soman, measurements 
were carried out with each of the purified diastereomers 
(C+P— and C+P+) since for the diastereomeric mixture 
only the aged product is expected to be formed within a few 
minutes after the phosphonylation (see Table 1 [28]). 
The mass spectrometric results for some of the phosphonyl-
HuAChE-bac adducts are presented in Fig. 1. For the iso-
propyl methylphosphonyl-HuAChE-bac (derived from reac-
tion with sarin), the molecular mass (Fig. IB) corresponds 
exactly to the sum of previously measured mass of the free 
enzyme and that of the phosphonyl moiety (64700+121). 
Mass measurement of the reaction product with IBMPF 
(Fig. 1C), which differs from sarin by one methyl group, 
gave a molecular mass of 64 840 (compared to the calculated 
mass 64700+135). For the (P+)-l,2,2-trimethylpropyl methyl-
phosphono-HuAChE-bac (Fig. ID), the observed molecular 
mass - 64 860 Da - corresponds to an intact somanyl adduct 
(calculated 64 700+163 Da) which is different by two and 
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Fig. 3. Positive-ion ESI-MS mass spectra of phosphono-HuAChE-bac conjugates, 7-10 h after phosphonylation. For all the cases shown, the 
molecular mass corresponds to a common product resulting from dealkylation the respective phosphonyl moieties (calculated 64778 Da). Note 
that these spectra are equivalent to that obtained for the phosphonylation product with (C+P—)-l,2,2-trimethylpropyl methylphosphonofluori-
date (see Fig. IE). 
three methyl groups from the corresponding adducts of 
IBMPF and sarin, respectively. These results demonstrate 
again the utility of the ESI-MS in monitoring chemical 
changes in enzymes, like HuAChE, and its accuracy in meas-
uring such high molecular masses with deviations of £ 5 Da 
(corresponding to the precision of 0.01% achievable by this 
method [42]). Furthermore, in accordance with the kinetic 
results (see Table 1), intact (non-'aged') phosphonyl-HuAChE 
adducts were observed for all the cases where the development 
of non-reactivability was slow. On the other hand, for the 
phosphonylation product with the (C+P—)-stereoisomer of 
soman, only an entity with molecular mass of 64 780 Da could 
be observed after 4 min (Fig. IE). This molecular mass cor-
responds almost exactly to that calculated (64 700+78 Da) of a 
dealkylated methylphosphonyl-HuAChE adduct resulting in 
the 'aging' process (see Scheme 1). Assuming that the progres-
sive non-reactivability of the other phosphonyl adducts orig-
inates from analogous dealkylation mechanism, the same 
dealkylation product (64 780 Da) should result in all cases 
(see Scheme 1). This point is clearly demonstrated by the 
behavior of 1,2-dimethylpropyl methyl-phosphono-HuAChE-
bac where the time frame of the development of non-reactiv-
ability (Table 1) makes it possible to actually follow the proc-
ess (see Fig. 2). Although the mass difference between the 
intact and aged adducts is too small to permit observation 
of two discrete masses, the molecular mass measured after 
10 min - 64852 Da (calculated for the intact adduct 
64700+149 Da, see Fig. 2A) and that measured after 7.5 h 
- 64780 Da (calcualted 64700+78 Da, see Fig. 2D), as well as 
the continuous shift of the mean mass (Fig. 2B,C) all indicate 
the progression of the dealkylation process. 
The notion that aging results in a common product for all 
the methylphosphonyl-HuAChE conjugates is further sup-
ported by measuring the composition of the sarin and IBMPF 
adducts after 7-10 h. In both cases, the adducts underwent 
conversion to molecular entities with the same mass (64 780 
Da, see Fig. 3A,B) as those resulting from (P—)-soman-Hu-
AChE and the DMPF conjugates (see Figs. IE and 3C). Since 
for all the adducts the time scale of this change is comparable 
to that of the kinetically observed aging process (Table 1), we 
can conclude that the aging indeed involves loss of alkyl 
group from the phosphonyl conjugate, as has been shown in 
the cases of trypsin [32] and chymotrypsin [33]. Furthermore, 
no other molecular species could be observed, indicating that 
Table 1 
Rate constants of phosphonylation (k\) and t1/2 
Soman 
C(+)P(-) 
h (XlO"5 min"1 M"1) 1500 
fi/2 (min) 5.3 
for the aging of soman, 
(C(+)P(+) 
<0.05 
> 40 000 
DMPF, IBMPF or sarin-inhibited HuAChE" at pH 8.0, 24°C 
DMPF 
2000 
130 
IBMPF Sarin 
1400 230 
255 2300 
"Expressed in mammalian cells. 
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in case of phosphonyl adducts, aging is the only mechanism 
responsible for non-reactivability. This point is further exem-
plified by both, the stability of the aged (P—)-soman-Hu-
A C h E adduct (Fig. IE) and by the continuous change ob-
served in the case of D M P F - H u A C h E adduct, where the 
only masses observed correspond to the transition between 
the non-aged and the aged (dealkylated) forms. On the other 
hand, the molecular mass of the P(+)-soman-HuAChE adduct 
remained unchanged after 10 h, in agreement with the already 
reported stability of the (P+)-soman-AChE adducts [48]. 
The ability to observe and sometime even to monitor the 
chemical transitions of H u A C h E covalent adducts by a direct 
determination of chemical composition may help to examine 
other cases where the post-inhibitory behavior of the adducts 
is not clear. The fact that the current ESI-MS method is 
applicable to enzyme preparations that are either non-glyco-
sylated or have a homogenous carbohydrate profile should 
not limit its utility for investigating various aspects of Hu-
A C h E function. Such aspects include, for example, the reac-
tivation properties of t abun-AChE adducts or the incomplete 
regeneration of enzymatic activity which is often observed 
following inhibition of H u A C h E enzymes by the presumably 
reversible active center inhibitor - m-(Af,iV,iV-trimethylammo-
nio)-trifluoroacetophenone [49]. The findings also exemplify 
the great potential of ESI-MS and related mass spectrometric 
techniques to the study of structure-function and reactivity 
characteristics of enzymes. 
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